| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/13/2023 | iTeos Therapeutics, Inc. | ITOS | Grant | Stock Option (Right to Buy) | 22.4k | $14.77 | $330.6k | | 06/13/2023 |
| 06/05/2023 | Jazz Pharmaceuticals plc | JAZZ | Disposition | Ordinary Shares | 1.3k | $129.73 | $170.1k | | 06/05/2023 |
| 05/03/2023 | Jounce Therapeutics, Inc. | JNCE | Disposition | Stock Option (Right to Buy) | 20k | $2.80 | $56k | | 05/03/2023 |
| 05/03/2023 | Jounce Therapeutics, Inc. | JNCE | Disposition | Stock Option (Right to Buy) | 15.7k | $7.27 | $114.1k | | 05/03/2023 |
| 05/03/2023 | Jounce Therapeutics, Inc. | JNCE | Disposition | Stock Option (Right to Buy) | 7.8k | $7.58 | $59.5k | | 05/03/2023 |
| 05/03/2023 | Jounce Therapeutics, Inc. | JNCE | Disposition | Stock Option (Right to Buy) | 31.4k | $7.19 | $225.8k | | 05/03/2023 |
| 03/05/2023 | Jazz Pharmaceuticals plc | JAZZ | Payment of Exercise | Ordinary Shares | 2.3k | $142.78 | $324.7k | | 03/03/2023 |
| 03/03/2023 | Jazz Pharmaceuticals plc | JAZZ | Grant | Ordinary Shares | 12.4k | $0.00 | $0 | | 03/03/2023 |
| 12/09/2022 | Jazz Pharmaceuticals plc | JAZZ | Sale | Ordinary Shares | 1.8k | $151.54 | $279.4k | | 12/09/2022 |
| 06/24/2022 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 20k | $2.80 | $56k | | 06/24/2022 |
| 06/09/2022 | iTeos Therapeutics, Inc. | ITOS | Grant | Stock Option (Right to Buy) | 17.5k | $18.78 | $329.4k | | 06/09/2022 |
| 06/06/2022 | Jazz Pharmaceuticals plc | JAZZ | Payment of Exercise | Ordinary Shares | 1.3k | $149.25 | $193.3k | | 06/06/2022 |
| 03/05/2022 | Jazz Pharmaceuticals plc | JAZZ | Payment of Exercise | Ordinary Shares | 1.3k | $153.96 | $204.3k | | 03/03/2022 |
| 03/03/2022 | Jazz Pharmaceuticals plc | JAZZ | Grant | Ordinary Shares | 11.4k | $0.00 | $0 | | 03/03/2022 |
| 06/18/2021 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 15.7k | $7.27 | $114.1k | | 06/18/2021 |
| 06/17/2021 | iTeos Therapeutics, Inc. | ITOS | Grant | Stock Option (Right to Buy) | 4.6k | $26.03 | $118.7k | | 06/17/2021 |
| 06/05/2021 | Jazz Pharmaceuticals plc | JAZZ | Payment of Exercise | Ordinary Shares | 1.2k | $176.47 | $212.8k | | 06/05/2021 |
| 04/29/2021 | iTeos Therapeutics, Inc. | ITOS | Grant | Stock Option (Right to Buy) | 33.2k | $24.11 | $800.9k | | 04/29/2021 |
| 03/05/2021 | Jazz Pharmaceuticals plc | JAZZ | Payment of Exercise | Ordinary Shares | 741 | $164.75 | $122.1k | | 03/05/2021 |
| 02/25/2021 | Jazz Pharmaceuticals plc | JAZZ | Grant | Ordinary Shares | 8.5k | $0.00 | $0 | | 02/25/2021 |
| 06/26/2020 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 7.8k | $7.58 | $59.5k | | 06/26/2020 |
| 06/05/2020 | Jazz Pharmaceuticals plc | JAZZ | Payment of Exercise | Ordinary Shares | 943 | $120.65 | $113.8k | | 06/05/2020 |
| 02/27/2020 | Jazz Pharmaceuticals plc | JAZZ | Grant | Ordinary Shares | 10.8k | $0.00 | $0 | | 02/27/2020 |
| 02/27/2020 | Jazz Pharmaceuticals plc | JAZZ | Grant | Incentive Stock Option (right to buy) | 884 | $113.10 | $100k | | 02/27/2020 |
| 02/27/2020 | Jazz Pharmaceuticals plc | JAZZ | Grant | Non-Qualified Stock Option (right to buy) | 26.1k | $113.10 | $3M | | 02/27/2020 |
| 01/21/2020 | Jounce Therapeutics, Inc. | JNCE | Grant | Stock Option (Right to Buy) | 31.4k | $7.19 | $225.8k | | 01/21/2020 |
| 08/08/2019 | Jazz Pharmaceuticals plc | JAZZ | Grant | Ordinary Shares | 12.2k | $0.00 | $0 | | 08/08/2019 |
| 08/08/2019 | Jazz Pharmaceuticals plc | JAZZ | Grant | Incentive Stock Option (right to buy) | 2.9k | $137.12 | $399.8k | | 08/08/2019 |
| 08/08/2019 | Jazz Pharmaceuticals plc | JAZZ | Grant | Non-Qualified Stock Option (right to buy) | 27.6k | $137.12 | $3.8M | | 08/08/2019 |
| 03/14/2019 | IMMUNOMEDICS INC | IMMU | Grant | Stock Option (right to buy) | 51.2k | $17.94 | $919.1k | | 03/14/2019 |
| 03/14/2019 | IMMUNOMEDICS INC | IMMU | Grant | Stock Option (right to buy) | 25.7k | $17.94 | $460.3k | | 03/14/2019 |
| 09/14/2018 | IMMUNOMEDICS INC | IMMU | Grant | Stock Options (right to buy) | 15.9k | $22.27 | $354.1k | | 09/14/2018 |